CAH Insider Notice: 42,870 Shares From Vested Equity to Be Sold on 08/19/2025

Rhea-AI Filing Summary

Cardinal Health (CAH) filed a Form 144 notifying the proposed sale of 42,870 common shares through Merrill (8890 Lyra Dr, Columbus, OH) on or about 08/19/2025. The filing reports an aggregate market value of $6,382,024.00 and shows 238,793,647 shares outstanding. The securities to be sold were acquired by the reporting person via performance stock vest (37,197 shares) and restricted stock vest (5,673 shares), with acquisition dates listed as 08/15/2025; a prior payment date of 02/15/2024 is noted for a portion of the holdings. No securities were reported sold by this person in the past three months. The filer certifies they are not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; proposed sale is small relative to outstanding shares and appears to reflect vested equity.

The Form 144 documents a proposed sale of 42,870 common shares valued at $6.38 million, executed through Merrill and arising from vested performance and restricted stock. The filing does not report any recent sales by the same person in the prior three months. From a market-impact perspective, the size represents a de minimis portion of the issuer's 238,793,647 outstanding shares, and the filing contains no information on planned sale timing beyond the approximate date. No earnings or operational disclosures are included.

Corporate Governance Expert

TL;DR: Disclosure aligns with compliance requirements; indicates exercise of compensation vesting rather than cash purchase.

The notice shows the securities stem from equity compensation events (performance and restricted stock vesting), with one tranche tied to a prior payment date. The signer attests absence of undisclosed material adverse information, consistent with Form 144 certification norms. There is no indication of a trading plan adoption date or other 10b5-1 details in the text provided. Governance implications are routine and procedural based on the content supplied.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	42870	6382024.00	238793647	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Performance stock vest	Cardinal Health			37197	02/15/2024	NA
Common	08/15/2025	Restricted stock vest	Cardinal Health			5673	08/15/2025	na

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cardinal Health's (CAH) Form 144 report?

The filing reports a proposed sale of 42,870 common shares with an aggregate market value of $6,382,024.00, to be sold approximately on 08/19/2025 through Merrill on the NYSE.

How were the shares acquired that are being sold?

The shares were acquired via equity compensation: 37,197 from a performance stock vest and 5,673 from a restricted stock vest, both with acquisition date 08/15/2025; a payment date of 02/15/2024 is noted for the larger tranche.

How many Cardinal Health shares are outstanding according to the filing?

The filing lists 238,793,647 shares outstanding.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the sale occur and on which exchange?

The sale is listed with Merrill (8890 Lyra Dr, Columbus, OH) and the exchange specified is the NYSE.